Before Invest
ELI LILLY & Co logo

ELI LILLY & Co

LLY
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 14 years
Format
% Change
Rows
USD ($)
$ in Millions 		Dec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010Dec 31, 2009
Current Assets
                 
Cash and cash equivalents
$ 7,268
$ 3,268
$ 2,819
Short-term investments (Note 7)
-
155
109
Accounts receivable
17,760
11,006
9,091
Other receivables
2,395
2,270
2,246
Inventories
13,744
7,589
5,773
Prepaid taxes
-
-
-
Deferred income taxes
-
-
-
Prepaid expenses
14,315
8,341
5,541
Other current assets
147
111
150
Prepaid expenses and other current assets
-
-
-
Current assets of discontinued operations (Note 19)
-
-
-
Total current assets
55,629
32,740
25,727
Noncurrent Assets
                 
Restricted cash
-
-
-
Investments
2,802
3,216
3,052
Goodwill
5,898
5,770
4,940
Other intangibles, net
6,521
6,166
6,907
Deferred tax assets
9,959
8,001
5,477
Total other assets
-
-
-
Property and equipment, net
24,675
17,102
12,914
Goodwill and other intangibles, net
-
-
-
Other noncurrent assets
6,992
5,720
4,990
Operating lease assets (Note 10)
-
-
-
Other noncurrent assets
-
-
-
Noncurrent assets of discontinued operations (Note 19)
-
-
-
Total assets
112,476
78,715
64,006
Liabilities and Equity
                 
Current Liabilities
                 
Short-term borrowings and current maturities of long-term debt
1,635
5,117
6,905
Accounts payable
5,379
3,229
2,599
Employee compensation
2,375
2,094
1,650
Sales rebates and discounts
17,382
11,539
11,689
Dividends payable
-
1,346
1,169
Income taxes payable (Note 14)
-
-
-
Deferred tax liabilities (Note 14)
-
-
-
Other current liabilities
8,457
5,051
3,281
Current liabilities of discontinued operations (Note 19)
-
-
-
Total current liabilities
35,228
28,377
27,293
Noncurrent Liabilities
                 
Long-term debt
40,868
28,527
18,321
Noncurrent operating lease liabilities (Note 10)
-
-
-
Accrued retirement benefits (Note 15)
-
1,301
1,439
Long-term income taxes payable
5,875
4,061
3,849
Other noncurrent liabilities
3,970
2,178
2,241
Noncurrent liabilities of discontinued operations (Note 19)
-
-
-
Total noncurrent liabilities
50,713
36,067
25,849
Equity
                 
Common stock—no par value Authorized shares: 3,200.0 Issued shares: 944.8 (2025) and 947.9 (2024)
590
592
594
Additional paid-in capital
7,346
7,439
7,250
Retained earnings
24,470
13,545
10,312
Employee benefit trust
3,013
3,013
3,013
Employee benefit trust
-
-
-
Deferred costs-ESOP
-
-
-
Accumulated other comprehensive loss
(2,880)
(4,322)
(4,327)
Other equity
22
-
-
Cost of common stock in treasury
-
50
44
Shareholders' equity, including treasury shares
-
-
-
Total equity
26,535
14,192
10,772
Noncontrolling interests
-
80
92
Total equity
-
14,272
10,864
Total liabilities and equity
$ 112,476
$ 78,715
$ 64,006